View ValuationH&R GmbH KGaA 将来の成長Future 基準チェック /36H&R GmbH KGaA利益と収益がそれぞれ年間96.7%と4%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に1.4% 96.6%なると予測されています。主要情報96.7%収益成長率96.61%EPS成長率Chemicals 収益成長43.0%収益成長率4.0%将来の株主資本利益率1.41%アナリストカバレッジLow最終更新日03 Jul 2026今後の成長に関する最新情報Price Target Changed • Nov 16Price target decreased to €6.50Down from €7.25, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of €6.52. Stock is down 21% over the past year. The company is forecast to post earnings per share of €1.01 for next year compared to €1.35 last year.Price Target Changed • Apr 27Price target decreased to €7.25Down from €8.25, the current price target is provided by 1 analyst. New target price is 21% above last closing price of €6.00. Stock is down 18% over the past year. The company is forecast to post earnings per share of €0.48 for next year compared to €1.35 last year.Price Target Changed • Feb 02Price target raised to €6.65Up from €5.90, the current price target is an average from 2 analysts. The new target price is 11% above the current share price of €6.00. As of last close, the stock is up 14% over the past year.すべての更新を表示Recent updatesNew Risk • Jul 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (8.7% average weekly change).Reported Earnings • May 20First quarter 2026 earnings released: EPS: €0.10 (vs €0.05 in 1Q 2025)First quarter 2026 results: EPS: €0.10 (up from €0.05 in 1Q 2025). Revenue: €300.2m (down 13% from 1Q 2025). Net income: €3.90m (up 106% from 1Q 2025). Profit margin: 1.3% (up from 0.5% in 1Q 2025). Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance.お知らせ • Apr 17H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2026H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2026, at 10:00 W. Europe Standard Time.お知らせ • Dec 18+ 3 more updatesH&R GmbH & Co. KGaA to Report Q3, 2026 Results on Nov 13, 2026H&R GmbH & Co. KGaA announced that they will report Q3, 2026 results on Nov 13, 2026お知らせ • Apr 17H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025H&R GmbH & Co. KGaA announced Annual dividend of EUR 0.1000 per share payable on May 30, 2025, ex-date on May 28, 2025 and record date on May 29, 2025.お知らせ • Apr 16H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2025H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2025, at 10:00 W. Europe Standard Time.お知らせ • Dec 13+ 3 more updatesH&R GmbH & Co. KGaA to Report Q3, 2025 Results on Nov 14, 2025H&R GmbH & Co. KGaA announced that they will report Q3, 2025 results on Nov 14, 2025Reported Earnings • Nov 17Third quarter 2024 earnings released: EPS: €0.09 (vs €0.20 in 3Q 2023)Third quarter 2024 results: EPS: €0.09 (down from €0.20 in 3Q 2023). Revenue: €348.7m (up 3.4% from 3Q 2023). Net income: €3.52m (down 54% from 3Q 2023). Profit margin: 1.0% (down from 2.2% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 16Second quarter 2024 earnings released: EPS: €0.03 (vs €0.13 in 2Q 2023)Second quarter 2024 results: EPS: €0.03 (down from €0.13 in 2Q 2023). Revenue: €347.5m (flat on 2Q 2023). Net income: €1.30m (down 72% from 2Q 2023). Profit margin: 0.4% (down from 1.3% in 2Q 2023). Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €4.05, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 56% over the past three years.Upcoming Dividend • May 22Upcoming dividend of €0.10 per shareEligible shareholders must have bought the stock before 29 May 2024. Payment date: 31 May 2024. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.0%).Reported Earnings • May 17First quarter 2024 earnings released: EPS: €0.04 (vs €0.03 loss in 1Q 2023)First quarter 2024 results: EPS: €0.04 (up from €0.03 loss in 1Q 2023). Revenue: €343.7m (down 1.5% from 1Q 2023). Net income: €1.47m (up €2.42m from 1Q 2023). Profit margin: 0.4% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Revenue is forecast to grow 8.9% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.Reported Earnings • Mar 30Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: €0.28 (down from €1.15 in FY 2022). Revenue: €1.35b (down 15% from FY 2022). Net income: €10.6m (down 75% from FY 2022). Profit margin: 0.8% (down from 2.7% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) also missed analyst estimates by 40%. Revenue is forecast to grow 8.0% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Declared Dividend • Mar 30Dividend of €0.10 announcedDividend of €0.10 is the same as last year. Ex-date: 29th May 2024 Payment date: 31st May 2024 Dividend yield will be 2.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (4% cash payout ratio). The dividend has decreased over the past 66 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 53% over the next 2 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Dec 21+ 4 more updatesH&R GmbH & Co. KGaA to Report Q2, 2024 Results on Aug 14, 2024H&R GmbH & Co. KGaA announced that they will report Q2, 2024 results on Aug 14, 2024Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: €0.13 (vs €0.58 in 2Q 2022)Second quarter 2023 results: EPS: €0.13 (down from €0.58 in 2Q 2022). Revenue: €358.1m (down 19% from 2Q 2022). Net income: €4.69m (down 78% from 2Q 2022). Profit margin: 1.3% (down from 4.9% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Upcoming Dividend • May 17Upcoming dividend of €0.10 per share at 1.9% yieldEligible shareholders must have bought the stock before 24 May 2023. Payment date: 26 May 2023. Trailing yield: 1.9%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.6%).Valuation Update With 7 Day Price Move • Apr 27Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €5.10, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 21% over the past three years.Buying Opportunity • Apr 05Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 2.5%. The fair value is estimated to be €7.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 12% in 2 years. Earnings is forecast to decline by 64% in the next 2 years.Reported Earnings • Apr 02Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €1.15 (down from €1.35 in FY 2021). Revenue: €1.58b (up 32% from FY 2021). Net income: €42.7m (down 15% from FY 2021). Profit margin: 2.7% (down from 4.2% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 14%. Revenue is expected to decline by 6.7% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.8%. Over the last 3 years on average, earnings per share has increased by 88% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Mar 01Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 3.6%. The fair value is estimated to be €7.55, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years.Buying Opportunity • Feb 14Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 7.3%. The fair value is estimated to be €7.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years.Buying Opportunity • Jan 25Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 8.5%. The fair value is estimated to be €7.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years.お知らせ • Dec 21+ 4 more updatesH&R GmbH & Co. KGaA to Report Q2, 2023 Results on Aug 18, 2023H&R GmbH & Co. KGaA announced that they will report Q2, 2023 results on Aug 18, 2023Price Target Changed • Nov 16Price target decreased to €6.50Down from €7.25, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of €6.52. Stock is down 21% over the past year. The company is forecast to post earnings per share of €1.01 for next year compared to €1.35 last year.Valuation Update With 7 Day Price Move • Oct 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to €6.48, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 8.0% over the past three years.Reported Earnings • Aug 17Second quarter 2022 earnings released: EPS: €0.58 (vs €0.64 in 2Q 2021)Second quarter 2022 results: EPS: €0.58 (down from €0.64 in 2Q 2021). Revenue: €453.6m (up 43% from 2Q 2021). Net income: €21.6m (down 8.8% from 2Q 2021). Profit margin: 4.8% (down from 7.5% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 11%, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 16First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €0.22 (up from €0.19 in 1Q 2021). Revenue: €368.8m (up 53% from 1Q 2021). Net income: €8.09m (up 12% from 1Q 2021). Profit margin: 2.2% (down from 3.0% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Over the next year, revenue is forecast to grow 6.7%, compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Price Target Changed • Apr 27Price target decreased to €7.25Down from €8.25, the current price target is provided by 1 analyst. New target price is 21% above last closing price of €6.00. Stock is down 18% over the past year. The company is forecast to post earnings per share of €0.48 for next year compared to €1.35 last year.Reported Earnings • Apr 01Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €1.35 (up from €0.24 loss in FY 2020). Revenue: €1.19b (up 35% from FY 2020). Net income: €50.2m (up €59.2m from FY 2020). Profit margin: 4.2% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Over the next year, revenue is forecast to grow 1.8%, compared to a 7.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS €0.43 (vs €0.03 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €325.2m (up 56% from 3Q 2020). Net income: €16.0m (up €17.3m from 3Q 2020). Profit margin: 4.9% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 4% per year.Reported Earnings • May 17First quarter 2021 earnings released: EPS €0.19 (vs €0.13 loss in 1Q 2020)The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: €248.5m (down 4.2% from 1Q 2020). Net income: €7.24m (up €12.0m from 1Q 2020). Profit margin: 2.9% (up from net loss in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 24Full year 2020 earnings released: €0.24 loss per share (vs €0.037 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: €878.5m (down 19% from FY 2019). Net loss: €9.02m (loss widened €7.65m from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance.Price Target Changed • Feb 02Price target raised to €6.65Up from €5.90, the current price target is an average from 2 analysts. The new target price is 11% above the current share price of €6.00. As of last close, the stock is up 14% over the past year.Is New 90 Day High Low • Jan 08New 90-day high: €5.85The company is up 19% from its price of €4.91 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.10 per share.Is New 90 Day High Low • Nov 28New 90-day high: €5.77The company is up 11% from its price of €5.22 on 28 August 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.40 per share.Analyst Estimate Surprise Post Earnings • Nov 17Revenue and earnings miss expectationsRevenue missed analyst estimates by 16%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 5.7%, compared to a 3.6% growth forecast for the Chemicals industry in Germany.Reported Earnings • Nov 17Third quarter 2020 earnings released: €0.03 loss per shareThe company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2020 results: Revenue: €213.3m (down 22% from 3Q 2019). Net loss: €1.21m (loss narrowed 80% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 98% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Oct 15New 90-day low: €4.87The company is down 18% from its price of €5.95 on 17 July 2020. The German market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.47 per share.お知らせ • Oct 05H&R Wasag AG to Report Q3, 2010 Results on 11/12/2010H&R Wasag AG announced that they will report Q3, 2010 results on 11/12/2010Is New 90 Day High Low • Sep 26New 90-day low: €5.12The company is down 4.0% from its price of €5.31 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.43 per share.業績と収益の成長予測DB:2HRA - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20281,36110-471212/31/20271,3308-666212/31/20261,2946-165423/31/20261,207-3765125N/A12/31/20251,253-393392N/A9/30/20251,2984565N/A6/30/20251,32683789N/A3/31/20251,35711-451N/A12/31/20241,348101570N/A9/30/20241,34062271N/A6/30/20241,339101968N/A3/31/20241,344132982N/A12/31/20231,3631161119N/A9/30/20231,3971483149N/A6/30/20231,478172196N/A3/31/20231,579341891N/A12/31/20221,58543-3238N/A9/30/20221,54043-4615N/A6/30/20221,44149-1635N/A3/31/20221,31451-1737N/A12/31/20211,19350-1237N/A9/30/20211,10753-1629N/A6/30/202199536-1622N/A3/31/202186033253N/A12/31/2020879-92260N/A9/30/2020906-201169N/A6/30/2020973-251384N/A3/31/20201,054-11-2755N/A12/31/20191,081-1N/A96N/A9/30/20191,1125N/A85N/A6/30/20191,12017N/A90N/A3/31/20191,13617N/A70N/A12/31/20181,12122N/A23N/A9/30/20181,08018N/A11N/A6/30/20181,05426N/A21N/A3/31/20181,03532N/A44N/A12/31/20171,03132N/A46N/A9/30/20171,02835N/A53N/A6/30/20171,01133N/A41N/A3/31/201798835N/A51N/A12/31/201694838N/A75N/A9/30/201692835N/A90N/A6/30/201692835N/A81N/A3/31/201695336N/A84N/A12/31/201598827N/A56N/A9/30/20151,02316N/A52N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 2HRAは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 1.9% ) よりも高い成長率であると考えられます。収益対市場: 2HRA今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。高成長収益: 2HRA今後 3 年以内に収益を上げることが予想されます。収益対市場: 2HRAの収益 ( 4% ) German市場 ( 6.6% ) よりも低い成長が予測されています。高い収益成長: 2HRAの収益 ( 4% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 2HRAの 自己資本利益率 は、3年後には低くなると予測されています ( 1.4 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/15 01:20終値2026/07/15 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋H&R GmbH & Co. KGaA 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7 アナリスト機関Volker BosseBaader Helvea Equity ResearchAlexandra RocheBerenbergJesko Mayer-WegelinHSBC4 その他のアナリストを表示
Price Target Changed • Nov 16Price target decreased to €6.50Down from €7.25, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of €6.52. Stock is down 21% over the past year. The company is forecast to post earnings per share of €1.01 for next year compared to €1.35 last year.
Price Target Changed • Apr 27Price target decreased to €7.25Down from €8.25, the current price target is provided by 1 analyst. New target price is 21% above last closing price of €6.00. Stock is down 18% over the past year. The company is forecast to post earnings per share of €0.48 for next year compared to €1.35 last year.
Price Target Changed • Feb 02Price target raised to €6.65Up from €5.90, the current price target is an average from 2 analysts. The new target price is 11% above the current share price of €6.00. As of last close, the stock is up 14% over the past year.
New Risk • Jul 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (8.7% average weekly change).
Reported Earnings • May 20First quarter 2026 earnings released: EPS: €0.10 (vs €0.05 in 1Q 2025)First quarter 2026 results: EPS: €0.10 (up from €0.05 in 1Q 2025). Revenue: €300.2m (down 13% from 1Q 2025). Net income: €3.90m (up 106% from 1Q 2025). Profit margin: 1.3% (up from 0.5% in 1Q 2025). Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 17H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2026H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2026, at 10:00 W. Europe Standard Time.
お知らせ • Dec 18+ 3 more updatesH&R GmbH & Co. KGaA to Report Q3, 2026 Results on Nov 13, 2026H&R GmbH & Co. KGaA announced that they will report Q3, 2026 results on Nov 13, 2026
お知らせ • Apr 17H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025H&R GmbH & Co. KGaA announced Annual dividend of EUR 0.1000 per share payable on May 30, 2025, ex-date on May 28, 2025 and record date on May 29, 2025.
お知らせ • Apr 16H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2025H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2025, at 10:00 W. Europe Standard Time.
お知らせ • Dec 13+ 3 more updatesH&R GmbH & Co. KGaA to Report Q3, 2025 Results on Nov 14, 2025H&R GmbH & Co. KGaA announced that they will report Q3, 2025 results on Nov 14, 2025
Reported Earnings • Nov 17Third quarter 2024 earnings released: EPS: €0.09 (vs €0.20 in 3Q 2023)Third quarter 2024 results: EPS: €0.09 (down from €0.20 in 3Q 2023). Revenue: €348.7m (up 3.4% from 3Q 2023). Net income: €3.52m (down 54% from 3Q 2023). Profit margin: 1.0% (down from 2.2% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 16Second quarter 2024 earnings released: EPS: €0.03 (vs €0.13 in 2Q 2023)Second quarter 2024 results: EPS: €0.03 (down from €0.13 in 2Q 2023). Revenue: €347.5m (flat on 2Q 2023). Net income: €1.30m (down 72% from 2Q 2023). Profit margin: 0.4% (down from 1.3% in 2Q 2023). Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €4.05, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 56% over the past three years.
Upcoming Dividend • May 22Upcoming dividend of €0.10 per shareEligible shareholders must have bought the stock before 29 May 2024. Payment date: 31 May 2024. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.0%).
Reported Earnings • May 17First quarter 2024 earnings released: EPS: €0.04 (vs €0.03 loss in 1Q 2023)First quarter 2024 results: EPS: €0.04 (up from €0.03 loss in 1Q 2023). Revenue: €343.7m (down 1.5% from 1Q 2023). Net income: €1.47m (up €2.42m from 1Q 2023). Profit margin: 0.4% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Revenue is forecast to grow 8.9% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
Reported Earnings • Mar 30Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: €0.28 (down from €1.15 in FY 2022). Revenue: €1.35b (down 15% from FY 2022). Net income: €10.6m (down 75% from FY 2022). Profit margin: 0.8% (down from 2.7% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) also missed analyst estimates by 40%. Revenue is forecast to grow 8.0% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Declared Dividend • Mar 30Dividend of €0.10 announcedDividend of €0.10 is the same as last year. Ex-date: 29th May 2024 Payment date: 31st May 2024 Dividend yield will be 2.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (4% cash payout ratio). The dividend has decreased over the past 66 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 53% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Dec 21+ 4 more updatesH&R GmbH & Co. KGaA to Report Q2, 2024 Results on Aug 14, 2024H&R GmbH & Co. KGaA announced that they will report Q2, 2024 results on Aug 14, 2024
Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: €0.13 (vs €0.58 in 2Q 2022)Second quarter 2023 results: EPS: €0.13 (down from €0.58 in 2Q 2022). Revenue: €358.1m (down 19% from 2Q 2022). Net income: €4.69m (down 78% from 2Q 2022). Profit margin: 1.3% (down from 4.9% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Upcoming Dividend • May 17Upcoming dividend of €0.10 per share at 1.9% yieldEligible shareholders must have bought the stock before 24 May 2023. Payment date: 26 May 2023. Trailing yield: 1.9%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.6%).
Valuation Update With 7 Day Price Move • Apr 27Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €5.10, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 21% over the past three years.
Buying Opportunity • Apr 05Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 2.5%. The fair value is estimated to be €7.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 12% in 2 years. Earnings is forecast to decline by 64% in the next 2 years.
Reported Earnings • Apr 02Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €1.15 (down from €1.35 in FY 2021). Revenue: €1.58b (up 32% from FY 2021). Net income: €42.7m (down 15% from FY 2021). Profit margin: 2.7% (down from 4.2% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 14%. Revenue is expected to decline by 6.7% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.8%. Over the last 3 years on average, earnings per share has increased by 88% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Mar 01Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 3.6%. The fair value is estimated to be €7.55, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years.
Buying Opportunity • Feb 14Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 7.3%. The fair value is estimated to be €7.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years.
Buying Opportunity • Jan 25Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 8.5%. The fair value is estimated to be €7.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years.
お知らせ • Dec 21+ 4 more updatesH&R GmbH & Co. KGaA to Report Q2, 2023 Results on Aug 18, 2023H&R GmbH & Co. KGaA announced that they will report Q2, 2023 results on Aug 18, 2023
Price Target Changed • Nov 16Price target decreased to €6.50Down from €7.25, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of €6.52. Stock is down 21% over the past year. The company is forecast to post earnings per share of €1.01 for next year compared to €1.35 last year.
Valuation Update With 7 Day Price Move • Oct 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to €6.48, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 8.0% over the past three years.
Reported Earnings • Aug 17Second quarter 2022 earnings released: EPS: €0.58 (vs €0.64 in 2Q 2021)Second quarter 2022 results: EPS: €0.58 (down from €0.64 in 2Q 2021). Revenue: €453.6m (up 43% from 2Q 2021). Net income: €21.6m (down 8.8% from 2Q 2021). Profit margin: 4.8% (down from 7.5% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 11%, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 16First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €0.22 (up from €0.19 in 1Q 2021). Revenue: €368.8m (up 53% from 1Q 2021). Net income: €8.09m (up 12% from 1Q 2021). Profit margin: 2.2% (down from 3.0% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Over the next year, revenue is forecast to grow 6.7%, compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Price Target Changed • Apr 27Price target decreased to €7.25Down from €8.25, the current price target is provided by 1 analyst. New target price is 21% above last closing price of €6.00. Stock is down 18% over the past year. The company is forecast to post earnings per share of €0.48 for next year compared to €1.35 last year.
Reported Earnings • Apr 01Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €1.35 (up from €0.24 loss in FY 2020). Revenue: €1.19b (up 35% from FY 2020). Net income: €50.2m (up €59.2m from FY 2020). Profit margin: 4.2% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Over the next year, revenue is forecast to grow 1.8%, compared to a 7.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS €0.43 (vs €0.03 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €325.2m (up 56% from 3Q 2020). Net income: €16.0m (up €17.3m from 3Q 2020). Profit margin: 4.9% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 4% per year.
Reported Earnings • May 17First quarter 2021 earnings released: EPS €0.19 (vs €0.13 loss in 1Q 2020)The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: €248.5m (down 4.2% from 1Q 2020). Net income: €7.24m (up €12.0m from 1Q 2020). Profit margin: 2.9% (up from net loss in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 24Full year 2020 earnings released: €0.24 loss per share (vs €0.037 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: €878.5m (down 19% from FY 2019). Net loss: €9.02m (loss widened €7.65m from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance.
Price Target Changed • Feb 02Price target raised to €6.65Up from €5.90, the current price target is an average from 2 analysts. The new target price is 11% above the current share price of €6.00. As of last close, the stock is up 14% over the past year.
Is New 90 Day High Low • Jan 08New 90-day high: €5.85The company is up 19% from its price of €4.91 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.10 per share.
Is New 90 Day High Low • Nov 28New 90-day high: €5.77The company is up 11% from its price of €5.22 on 28 August 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.40 per share.
Analyst Estimate Surprise Post Earnings • Nov 17Revenue and earnings miss expectationsRevenue missed analyst estimates by 16%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 5.7%, compared to a 3.6% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Nov 17Third quarter 2020 earnings released: €0.03 loss per shareThe company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2020 results: Revenue: €213.3m (down 22% from 3Q 2019). Net loss: €1.21m (loss narrowed 80% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 98% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Oct 15New 90-day low: €4.87The company is down 18% from its price of €5.95 on 17 July 2020. The German market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.47 per share.
お知らせ • Oct 05H&R Wasag AG to Report Q3, 2010 Results on 11/12/2010H&R Wasag AG announced that they will report Q3, 2010 results on 11/12/2010
Is New 90 Day High Low • Sep 26New 90-day low: €5.12The company is down 4.0% from its price of €5.31 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.43 per share.